Demographics

Study: Paxlovid safe, effective in pregnancy EmiliaU / iStock CIDRAP

A study based on 211 pregnant women given the antiviral drug nirmatrelvir and ritonavir (Paxlovid) during pregnancy for acute COVID-19 infections shows no increased risk of adverse events in the women or their babies and a reduced risk of complications called the maternal morbidity and mortality index (MMMI).

The findings, published today in Nature Medicine, suggest the drug is safe to use in pregnancy and is effective in reducing MMMI risk but not COVID-related hospitalizations.

...

Why is COVID-19 more severe in some people? Researchers use genetics, data science to find out Why do some people have a more severe course of COVID-19 disease than others? A genome sequence database created by an international collaboration of researchers, including many from the University of ... Tyler Irving Medical Xpress

Why do some people have a more severe course of COVID-19 disease than others? A genome sequence database created by an international collaboration of researchers, including many from the University of Toronto and partner hospitals, may hold the answers to this question—and many more.

...

People with HIV at higher risk of COVID reinfection: CDC A new CDC study found people with HIV were more likely to be reinfected with COVID than those without HIV. ABC News ABC News

...

Rates of reinfection were higher among people with HIV (6.7%) than among people without HIV (5.2%).

People with HIV are more likely to have completed a primary COVID vaccine series plus a booster before their reinfection -- 31.8% versus 27% for those without HIV.

As RSV cases tick up, CDC warns that a key drug to keep babies safe is in short supply The CDC's alert says the highest dosage of the drug, called Beyfortus, is in limited supply. NBC News

... The agency told doctors to prioritize getting those doses to infants at the highest risk of severe RSV, including infants younger than 6 months and those with underlying conditions. The CDC also advised doctors to preserve 50 mg doses for infants who weigh less than 11 pounds.